Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Generex Biotechnology Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Generex Biotechnology Corp market cap is $100.00.
What is the 52-week high for Generex Biotechnology Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Generex Biotechnology Corp 52 week high is $0.0804 as of September 06, 2025.
What is the 52-week low for Generex Biotechnology Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Generex Biotechnology Corp 52 week low is $0.00 as of September 06, 2025.
What was Generex Biotechnology Corp stock price yesterday?
Generex Biotechnology Corp stock price yesterday was $0.000001.
What is the 50-day moving average of Generex Biotechnology Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Generex Biotechnology Corp 50-day moving average is $0.0001.